Coloplast A/S - Transactions in connection with share buy-back programme, week 12

---

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

---

As mentioned in Announcement no. 02/2021 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.

The following transactions have been executed during the period 22 – 26 March 2021:

Date	Number of shares	Average purchase price, DKK	Transaction value, DKK
22 March 2021	300	936.68	281,004
23 March 2021	400	963.32	385,328
24 March 2021	1,000	957.35	957,350
25 March 2021	300	955.50	286,650
26 March 2021	500	955.29	477,645
Accumulated until now under the programme	61,450	911.03	55,982,589

Henceforth, Coloplast owns 3,097,347 treasury B shares of DKK 1 equal to 1.43% of the company’s total share capital.  

An overview showing the transaction data for the period 22 – 26 March 2021 is enclosed.

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

 

For further information, please contact
  
Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376
Email: dkebj@coloplast.com

Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com                                                                       

Press and the media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-03.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachments

• 29032021_Sharebuyback_week_12
• Transaction data_week_12

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Correction: VÍS - Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun
• Clean Power Capital Announces Application to List its Common Shares on the NASDAQ Capital Market and Uplisting to NEO Exchange
• VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of EVAPORATE Study Presented as Late-Breaking Science at ESC Preventive Cardiology 2021